MoneyWorks4Me

Lupin submits press release

23 Sep 2019 Evaluate

Lupin has informed about submission of a Press Release as regards completion of the US FDA inspection carried out at the Company's Torapur manufacturing (API) facility between September 16 to September 20, 2019. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..